Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves et al

Affiliations

• ¹ AMC, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.
• ² Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands.
• ³ Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands.
• ⁴ Clinical Immunology & Rheumatology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, The Netherlands.
• ⁵ Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK laura.coates@ndorms.ox.ac.uk.